France In Vitro Fertilization Market Size & Outlook

The in vitro fertilization market in France is expected to reach a projected revenue of US$ 1,808.8 million by 2030. A compound annual growth rate of 4.1% is expected of France in vitro fertilization market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,366.5
Forecast, 2030 (US$M)
$1,808.8
CAGR, 2024 - 2030
4.1%
Report Coverage
France

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France in vitro fertilization market, 2018-2030 (US$M)

France in vitro fertilization market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France in vitro fertilization market highlights

  • The France in vitro fertilization market generated a revenue of USD 1,366.5 million in 2023 and is expected to reach USD 1,808.8 million by 2030.
  • The France market is expected to grow at a CAGR of 4.1% from 2024 to 2030.
  • In terms of segment, frozen nondonor was the largest revenue generating procedure type in 2023.
  • Frozen Nondonor is the most lucrative procedure type segment registering the fastest growth during the forecast period.


In vitro fertilization market data book summary

Market revenue in 2023USD 1,366.5 million
Market revenue in 2030USD 1,808.8 million
Growth rate4.1% (CAGR from 2023 to 2030)
Largest segmentFrozen nondonor
Fastest growing segmentFrozen Nondonor
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationFresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor
Key market players worldwideBayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility


Other key industry trends

  • In terms of revenue, France accounted for 5.4% of the global in vitro fertilization market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany in vitro fertilization market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 2,277.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vitro Fertilization Market Companies

Name Profile # Employees HQ Website
US Fertility View profile 1001-5000 Rockville, Maryland, United States, North America https://www.usfertility.com/
TFP Fertility Group View profile 501-1000 Oxford, Oxfordshire, United Kingdom, Europe https://tfp-fertility.com/
RMA Network View profile 101-250 Basking Ridge, New Jersey, United States, North America https://rmanetwork.com/
Fortis Healthcare View profile 10001+ Gurgaon, Haryana, India, Asia http://fortishealthcare.com
Nova IVF View profile 11-50 Mountain View, California, United States, North America https://www.novaivf.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
Cook Medical View profile 10001+ Bloomington, Indiana, United States, North America http://www.cookmedical.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Genea Biomedx View profile 101-250 Sydney, New South Wales, Australia, Oceania https://www.geneabiomedx.com
The Cooper Companies Inc View profile 15000 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, United States, 94583 https://www.coopercos.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
FUJIFILM Holdings Corp View profile 83784 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 http://www.fujifilmholdings.com
Vitrolife AB ADR View profile 1116 Box 9080, Gothenburg, Sweden, 400 92 https://www.vitrolife.com
Boston Scientific Corp View profile 48000 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 https://www.bostonscientific.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

France in vitro fertilization market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.


Frozen nondonor was the largest segment with a revenue share of 48.35% in 2023. Horizon Databook has segmented the France in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.


In France, a majority of fertility treatments involve the use of intra-partner gametes, and the use of donated gametes is very rare. The prevalence of infertility has been on the rise in France, contributing to the demand for IVF treatments. Various factors, such as lifestyle changes, environmental factors, and medical conditions, can impact fertility, leading more individuals and couples to seek fertility assistance.

According to a report presented in 2022 to the Ministry of Health, infertility is considered a significant public health issue in France, affecting one in four couples of childbearing age. Government initiatives in France are expected to stimulate and enhance the demand for fertility treatments, including IVF.

These initiatives aim to address the growing concern surrounding infertility as a public health issue and provide support for couples facing fertility challenges. For instance, in June 2021, the lower house of parliament in France officially passed a law granting single women and lesbian couples access to medically assisted reproduction.

Reasons to subscribe to France in vitro fertilization market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France in vitro fertilization market databook

  • Our clientele includes a mix of in vitro fertilization market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into France in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France in vitro fertilization market size, by procedure type, 2018-2030 (US$M)

France In Vitro Fertilization Market Outlook Share, 2023 & 2030 (US$M)

France in vitro fertilization market size, by procedure type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online